Healthcare -
Biotechnology - NASDAQ - US
$ 8.67
9.61 %
$ 738 M
Market Cap
-15.76
P/E
AVXL - CASH & EQUIVALENTS
Cash & Equivalents AVXL - Anavex Life Sciences Corp.
132 M
LAST VALUE
-5.86%
2 YEAR CAGR
42.90%
5 YEAR CAGR
33.66%
10 YEAR CAGR